The combination demonstrated to be safe and tolerable, and analysis of the tumor-immune contexture demonstrated the up-regulation of immune-related molecules, such as HLA class I, and an increase in CD8+T cells infiltration (95), as well as re-expression of immuno-modulatory endogenous retroviruses and other repetitive elements (96). The gene discussed is CD8A; the disease is neoplasm.